Using the ProteOn™ XPR36 to Characterize Human-Derived Monoclonal Antibodies Against Influenza Virus



March 15, 2017

"For more information, visit Different strains of Influenza virus include a great diversity of antigenic proteins, often requiring annual vaccination for strain-specific protection. This webinar focuses on the use of the ProteOn XPR36 system to determine the cross-reactivity and binding kinetics of a panel of human-derived monoclonal antibodies against the H3 hemagglutinin protein in multiple Influenza strains. The ability to robustly measure the binding affinities of a panel of antibodies with numerous antigens using the ProteOn system is a powerful platform that is applicable to many experimental systems. It allows real-time comparison of multiple interactions on a single chip, and provides high throughput in obtaining the screening result. Presenter: Dr Lisa Scalfone, Postdoctoral Fellow Stanford University School of Medicine"

Drug Discovery

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.